Skip to main content
. 2018 May 22;11(2):50. doi: 10.3390/ph11020050

Figure 1.

Figure 1

Top panel: design of first-generation side chain carboxylated cannabinoid analogs, with controllable deactivation and increasing polarity, and structures of the prototype (-)-Δ8-THC-DMH and inactive metabolites. Lower panel: design principles and biological activity data for representative analogs.